Stocksigma LogoStocksigma Logo

Gujarat Kidney & Super Speciality Q2 FY27 Results

Gujarat Kidney & Super Speciality reported Q2 FY27 revenue from operations of ₹3,809 lakhs (+194.6% YoY, +11.1% QoQ), with EBITDA rising 99.4% YoY to

Gujarat Kidney & Super Speciality Q2 FY27 Results

Gujarat Kidney and Super Speciality Ltd · Investor Presentation · 05 Nov 2026, 4:44 pm

Gujarat Kidney & Super Speciality Q2 FY27 Results Gujarat Kidney & Super Speciality reported Q2 FY27 revenue from operations of ₹3,809 lakhs (+194.6% YoY, +11.1% QoQ), with EBITDA rising 99.4% YoY to ₹1,022 lakhs (26.8% margin) and PAT surging 129.4% YoY to ₹660 lakhs. For H1 FY27, revenue reached ₹7,238 lakhs (+156.8% YoY) and PAT stood at ₹1,192 lakhs (+44.0% YoY). Growth was driven by network acquisitions, deploying ₹1,669 lakhs in H1, alongside a 51% acquisition in Dubai's Blue Tree Clinics. As of 30th Sep'26, the company maintained a net cash position of ₹1,488 lakhs.

Original exchange filing (PDF)

More announcements from Gujarat Kidney and Super Speciality Ltd

All Gujarat Kidney and Super Speciality Ltd announcements